查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1726339

全球基於 NGS 的 RNA 定序市場：市場規模、佔有率、趨勢分析（按產品/服務、工作流程、應用、最終用途和地區）、細分市場預測（2025-2030 年）

NGS-based RNA-sequencing Market Size, Share & Trends Analysis Report By Product & Service, By Workflow, By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

基於NGS的RNA定序市場成長與趨勢：

根據 Grand View Research, Inc. 的新報告，全球基於 NGS 的 RNA 定序市場規模預計到 2030 年將達到 100.5 億美元，2025 年至 2030 年的複合年成長率為 17.3%。

這種成長是由精準醫療需求的不斷成長、測序技術的進步以及診斷、藥物發現和疾病研究領域應用的不斷擴大所推動的。生物資訊能力的不斷擴大和測序成本的下降進一步推動了市場應用。

COVID-19 大流行加速了基於 NGS 的 RNA 測序的採用，因為它在了解病毒突變、宿主反應和病原體轉錄組學方面發揮關鍵作用。疫苗和治療開發中迫切需要先進的基因組工具，凸顯了 RNA 定序的價值，並促使其迅速融入研究和公共衛生工作。這種轉變進一步增強了RNA定序在感染疾病監測和預防中的重要性。

此外，高通量定序技術的進步顯著提高了 RNA 定序的速度、準確性和可擴展性。這些創新使得轉錄組分析更加全面、週轉時間更快、成本更低，並且使基於 NGS 的 RNA 定序更適用於研究和臨床應用。

然而，定序平台和基礎設施的高初始成本，以及對使用基因組數據的道德擔憂，預計會阻礙市場成長。這些挑戰可能會限制採用，特別是在資源受限的環境和資料隱私法規嚴格的地區。

基於NGS的RNA定序市場報告重點

  • 按產品和服務分類，由於試劑化學的不斷進步以及對高品質、高效測序試劑套件的需求不斷增加，預計耗材部門將在 2024 年佔據最大的收益佔有率，達到 58.12%。然而，預計在預測期內服務業將以最快的複合年成長率成長。
  • 根據工作流程，由於擴大採用提供快速週轉和具有成本效益的處理的先進平台，預計定序部分將在 2024 年佔據最大的市場佔有率。另一方面，數據分析部分預計在預測期內實現 18.49% 的複合年成長率。
  • 根據應用，藥物發現和開發將在 2024 年佔據應用領域最大的收益佔有率。這是由於 RNA 定序在識別新標靶和加速治療方法開發方面的應用日益增加。然而，臨床診斷領域預計在預測期內的複合年成長率最高。
  • 根據最終用途，製藥和生物技術公司在 2024 年佔據最大佔有率。這種成長是由 RNA 測序在生物標記發現、臨床研究和個人化藥物開發中的日益普及所推動的。另一方面，醫院和診所部門預計在預測期內將實現最快的成長率。
  • 由於先進的醫療基礎設施、強大的研究資金以及精準醫療和基因組技術的高度採用等因素，北美在基於 NGS 的 RNA 測序市場中佔據主導地位。預計在預測期內亞太地區將以最快的複合年成長率成長。

目錄

第1章 分析方法與範圍

第2章執行摘要

3. 基於NGS的RNA定序市場：促進因素、趨勢與範圍

  • 市場聯動展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制分析
  • 基於NGS的RNA定序市場：分析工具
    • 產業分析：波特五力分析
    • PESTEL分析
    • COVID-19影響分析

第4章基於NGS的RNA定序市場：按產品和服務的估計和趨勢分析

  • 產品/服務儀表板
  • 全球基於NGS的RNA定序市場（依變異分析、產品和服務）
  • 全球基於 NGS 的 RNA 定序市場：按產品和服務分類的市場規模和趨勢分析（2018-2030 年）
  • 耗材
    • 萃取精製套件
    • 樣品製備套件
    • 定序試劑和流動槽
    • 其他
  • 裝置
  • 服務
    • RNA定序
    • 生物資訊數據分析

5. 以NGS為基礎的RNA定序市場：依工作流程的估算與趨勢分析

  • 工作流程儀表板
  • 全球基於NGS的RNA定序市場（按變異分析和工作流程）
  • 全球基於 NGS 的 RNA 定序市場：按工作流程分類的市場規模和趨勢分析（2018-2030 年）
  • 前序列
  • 定序
  • 數據分析

6. 基於NGS的RNA定序市場：按應用的估值和趨勢分析

  • 特定於應用程式的儀表板
  • 全球基於NGS的RNA定序市場（依變異分析與應用）
  • 全球基於 NGS 的 RNA 定序市場：按應用分類的市場規模和趨勢分析（2018-2030 年）
  • 應用程式細分儀表板
  • 全球基於NGS的RNA定序市場應用差異分析
  • 2018-2030年全球基於NGS的RNA定序市場規模及應用趨勢分析
  • 藥物研發
    • 瘤
    • 感染疾病
    • 其他
  • 臨床診斷
  • 其他

7. 以NGS為基礎的RNA定序市場：依最終用途的估算與趨勢分析

  • 最終用途儀表板
  • 全球基於NGS的RNA定序市場（按變異分析和最終用途）
  • 全球基於 NGS 的 RNA 定序市場：按最終用途分類的市場規模和趨勢分析（2018-2030 年）
  • 製藥和生物技術公司
  • 醫院和診所
  • 學術研究所
  • 其他

第 8 章基於 NGS 的 RNA定序市場：區域估計和趨勢分析（按產品/服務、工作流程、應用和最終用途）

  • 各地區市場佔有率分析（2024 年及 2030 年）
  • 市場儀表板：按地區
  • 市場規模預測及趨勢分析（2018-2030年）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭態勢

  • 公司/競爭對手分類
  • 戰略地圖
  • 企業市場分析（2024年）
  • 公司簡介/上市公司
    • Illumina, Inc.
    • Thermo Fisher Scientific Inc.
    • QIAGEN NV
    • Merck KGaA
    • Pacific Biosciences of California, Inc.
    • Oxford Nanopore Technologies Ltd.
    • BGI Group
    • Agilent Technologies, Inc.
    • Roche Holding AG
    • Revvity, Inc.
Product Code: GVR-4-68040-560-4

NGS-based RNA-sequencing Market Growth & Trends:

The global NGS-based RNA-sequencing market size is expected to reach USD 10.05 billion by 2030 and is anticipated to grow at a CAGR of 17.3% from 2025 to 2030, according to a new report by Grand View Research, Inc. This growth is attributed to rising demand for precision medicine, advancements in sequencing technologies, and increasing applications in diagnostics, drug discovery, and disease research. Expanding bioinformatics capabilities and declining sequencing costs further support widespread market adoption.

The COVID-19 pandemic has accelerated the adoption of NGS-based RNA-sequencing owing to its critical role in understanding viral mutations, host response, and pathogen transcriptomics. The urgent need for advanced genomic tools in vaccine and therapeutic development highlighted the value of RNA-sequencing, driving rapid integration into research and public health efforts. This shift has reinforced its importance in infectious disease monitoring and preparedness.

In addition, advancements in high-throughput sequencing technologies have significantly enhanced the speed, accuracy, and scalability of RNA-sequencing. These innovations enable more comprehensive transcriptome profiling, reduce turnaround times, and lower costs, making NGS-based RNA sequencing more accessible for both research and clinical applications.

However, high initial costs associated with sequencing platforms and infrastructure, and ethical concerns surrounding genomic data usage are expected to hamper market growth. These challenges may limit adoption, particularly in resource-constrained settings and regions with stringent data privacy regulations.

NGS-based RNA-sequencing Market Report Highlights:

  • Based on product and service, the consumables segment dominated with the largest revenue share of 58.12% in 2024, due to continuous advancements in reagent chemistry and the growing demand for quality, efficient sequencing kits. However, services are expected to grow at the fastest CAGR over the forecast period.
  • Based on workflow, the sequencing segment held the largest market share in 2024, driven by increased adoption of advanced platforms offering faster turnaround and cost-effective processing. On the other hand, the data analysis segment is anticipated to witness the fastest CAGR of 18.49% over the forecast period.
  • Based on application, the drug discovery & development segment holds the largest revenue share for application in 2024. This is attributed to the growing use of RNA-sequencing in identifying novel targets and accelerating therapeutic development. However, the clinical diagnostics segment is projected to grow at the highest CAGR over the forecast period.
  • Based on end use, the pharmaceutical & biotechnology companies segment held the largest share in 2024. The growth is due to increased adoption of RNA-sequencing for biomarker discovery, clinical research, and personalized drug development. On the other hand, the hospitals & clinics segment is expected to register the fastest growth rate during the projected period.
  • North America dominated the NGS-based RNA-sequencing market owing to factors such as advanced healthcare infrastructure, strong research funding, and high adoption of precision medicine and genomic technologies. Asia Pacific is expected to grow at the fastest CAGR during the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Product & Service
    • 1.2.2. Workflow
    • 1.2.3. Application
    • 1.2.4. End Use
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. NGS-based RNA-sequencing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising demand for precision and personalized medicine
      • 3.2.1.2. Growing applications in biomarker discovery and drug development
      • 3.2.1.3. Integration of AI and bioinformatics for data interpretation
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High initial costs associated with sequencing platforms and infrastructure
      • 3.2.2.2. Ethical issues surrounding genomic data usage
  • 3.3. NGS-based RNA-sequencing Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. NGS-based RNA-sequencing Market: Product & Service Estimates & Trend Analysis

  • 4.1. Product & Service Segment Dashboard
  • 4.2. Global NGS-based RNA-sequencing Market Product & Service Movement Analysis
  • 4.3. Global NGS-based RNA-sequencing Market Size & Trend Analysis, by Product & Service, 2018 to 2030 (USD Million)
  • 4.4. Consumables
    • 4.4.1. Consumables market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Extraction & Purification Kits
      • 4.4.2.1. Extraction & purification kits market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Library Preparation Kits
      • 4.4.3.1. Library preparation kits market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.4. Sequencing Reagents & Flow Cells
      • 4.4.4.1. Sequencing reagents & flow cells market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.5. Others
      • 4.4.5.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Instruments
    • 4.5.1. Instruments market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Services
    • 4.6.1. Services market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.2. RNA-sequencing
      • 4.6.2.1. RNA-sequencing market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.3. Bioinformatics & Data Analysis
      • 4.6.3.1. Bioinformatics & data analysis market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. NGS-based RNA-sequencing Market: Workflow Estimates & Trend Analysis

  • 5.1. Workflow Segment Dashboard
  • 5.2. Global NGS-based RNA-sequencing Market Workflow Movement Analysis
  • 5.3. Global NGS-based RNA-sequencing Market Size & Trend Analysis, by Workflow, 2018 to 2030 (USD Million)
  • 5.4. Pre-sequencing
    • 5.4.1. Pre-sequencing market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Sequencing
    • 5.5.1. Sequencing market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Data Analysis
    • 5.6.1. Data analysis market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. NGS-based RNA-sequencing Market: Application Estimates & Trend Analysis

  • 6.1. Application Segment Dashboard
  • 6.2. Global NGS-based RNA-sequencing Market Application Movement Analysis
  • 6.3. Global NGS-based RNA-sequencing Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 6.4. Drug Discovery & Development
    • 6.4.1. Drug discovery & development market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.2. Oncology
      • 6.4.2.1. Oncology market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.3. Infectious Diseases
      • 6.4.3.1. Infectious diseases market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.4. Others
      • 6.4.4.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Clinical Diagnostics
    • 6.5.1. Clinical diagnostics market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. NGS-based RNA-sequencing Market: End Use Estimates & Trend Analysis

  • 7.1. End Use Segment Dashboard
  • 7.2. Global NGS-based RNA-sequencing Market End Use Movement Analysis
  • 7.3. Global NGS-based RNA-sequencing Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 7.4. Pharmaceutical & Biotechnology Companies
    • 7.4.1. Pharmaceutical & biotechnology companies market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Hospitals & Clinics
    • 7.5.1. Hospitals & clinics market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Academic & Research Institutes
    • 7.6.1. Academic & research institutes market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. Others
    • 7.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. NGS-based RNA-sequencing Market: Regional Estimates & Trend Analysis by Product & Service, Workflow, Application, and End Use

  • 8.1. Regional Market Share Analysis, 2024 & 2030
  • 8.2. Regional Market Dashboard
  • 8.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 8.4. North America
    • 8.4.1. North America market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.2. U.S.
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. Regulatory framework
      • 8.4.2.3. Competitive scenario
      • 8.4.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.3. Canada
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Regulatory framework
      • 8.4.3.3. Competitive scenario
      • 8.4.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.4. Mexico
      • 8.4.4.1. Key country dynamics
      • 8.4.4.2. Regulatory framework
      • 8.4.4.3. Competitive scenario
      • 8.4.4.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5. Europe
    • 8.5.1. Europe market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.2. UK
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Regulatory framework
      • 8.5.2.3. Competitive scenario
      • 8.5.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.3. Germany
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Regulatory framework
      • 8.5.3.3. Competitive scenario
      • 8.5.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.4. France
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Regulatory framework
      • 8.5.4.3. Competitive scenario
      • 8.5.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.5. Italy
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Regulatory framework
      • 8.5.5.3. Competitive scenario
      • 8.5.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.6. Spain
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Regulatory framework
      • 8.5.6.3. Competitive scenario
      • 8.5.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.7. Norway
      • 8.5.7.1. Key country dynamics
      • 8.5.7.2. Regulatory framework
      • 8.5.7.3. Competitive scenario
      • 8.5.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.8. Sweden
      • 8.5.8.1. Key country dynamics
      • 8.5.8.2. Regulatory framework
      • 8.5.8.3. Competitive scenario
      • 8.5.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.9. Denmark
      • 8.5.9.1. Key country dynamics
      • 8.5.9.2. Regulatory framework
      • 8.5.9.3. Competitive scenario
      • 8.5.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Asia Pacific market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.2. Japan
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Regulatory framework
      • 8.6.2.3. Competitive scenario
      • 8.6.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.3. China
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. Regulatory framework
      • 8.6.3.3. Competitive scenario
      • 8.6.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.4. India
      • 8.6.4.1. Key country dynamics
      • 8.6.4.2. Regulatory framework
      • 8.6.4.3. Competitive scenario
      • 8.6.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.5. Australia
      • 8.6.5.1. Key country dynamics
      • 8.6.5.2. Regulatory framework
      • 8.6.5.3. Competitive scenario
      • 8.6.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.6. South Korea
      • 8.6.6.1. Key country dynamics
      • 8.6.6.2. Regulatory framework
      • 8.6.6.3. Competitive scenario
      • 8.6.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.7. Thailand
      • 8.6.7.1. Key country dynamics
      • 8.6.7.2. Regulatory framework
      • 8.6.7.3. Competitive scenario
      • 8.6.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Latin America market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.2. Brazil
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Regulatory framework
      • 8.7.2.3. Competitive scenario
      • 8.7.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.3. Argentina
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Regulatory framework
      • 8.7.3.3. Competitive scenario
      • 8.7.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8. MEA
    • 8.8.1. MEA market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.2. South Africa
      • 8.8.2.1. Key country dynamics
      • 8.8.2.2. Regulatory framework
      • 8.8.2.3. Competitive scenario
      • 8.8.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.3. Saudi Arabia
      • 8.8.3.1. Key country dynamics
      • 8.8.3.2. Regulatory framework
      • 8.8.3.3. Competitive scenario
      • 8.8.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.4. UAE
      • 8.8.4.1. Key country dynamics
      • 8.8.4.2. Regulatory framework
      • 8.8.4.3. Competitive scenario
      • 8.8.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.5. Kuwait
      • 8.8.5.1. Key country dynamics
      • 8.8.5.2. Regulatory framework
      • 8.8.5.3. Competitive scenario
      • 8.8.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company/Competition Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Market Position Analysis, 2024
  • 9.4. Company Profiles/Listing
    • 9.4.1. Illumina, Inc.
      • 9.4.1.1. Company overview
      • 9.4.1.2. Financial performance
      • 9.4.1.3. Product benchmarking
      • 9.4.1.4. Strategic initiatives
    • 9.4.2. Thermo Fisher Scientific Inc.
      • 9.4.2.1. Company overview
      • 9.4.2.2. Financial performance
      • 9.4.2.3. Product benchmarking
      • 9.4.2.4. Strategic initiatives
    • 9.4.3. QIAGEN N.V.
      • 9.4.3.1. Company overview
      • 9.4.3.2. Financial performance
      • 9.4.3.3. Product benchmarking
      • 9.4.3.4. Strategic initiatives
    • 9.4.4. Merck KGaA
      • 9.4.4.1. Company overview
      • 9.4.4.2. Financial performance
      • 9.4.4.3. Product benchmarking
      • 9.4.4.4. Strategic initiatives
    • 9.4.5. Pacific Biosciences of California, Inc.
      • 9.4.5.1. Company overview
      • 9.4.5.2. Financial performance
      • 9.4.5.3. Product benchmarking
      • 9.4.5.4. Strategic initiatives
    • 9.4.6. Oxford Nanopore Technologies Ltd.
      • 9.4.6.1. Company overview
      • 9.4.6.2. Financial performance
      • 9.4.6.3. Product benchmarking
      • 9.4.6.4. Strategic initiatives
    • 9.4.7. BGI Group
      • 9.4.7.1. Company overview
      • 9.4.7.2. Financial performance
      • 9.4.7.3. Product benchmarking
      • 9.4.7.4. Strategic initiatives
    • 9.4.8. Agilent Technologies, Inc.
      • 9.4.8.1. Company overview
      • 9.4.8.2. Financial performance
      • 9.4.8.3. Product benchmarking
      • 9.4.8.4. Strategic initiatives
    • 9.4.9. Roche Holding AG
      • 9.4.9.1. Company overview
      • 9.4.9.2. Financial performance
      • 9.4.9.3. Product benchmarking
      • 9.4.9.4. Strategic initiatives
    • 9.4.10. Revvity, Inc.
      • 9.4.10.1. Company overview
      • 9.4.10.2. Financial performance
      • 9.4.10.3. Product benchmarking
      • 9.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global NGS-based RNA-sequencing market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global NGS-based RNA-sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 4 Global NGS-based RNA-sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 5 Global NGS-based RNA-sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 6 Global NGS-based RNA-sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 7 North America NGS-based RNA-sequencing market, by country, 2018 - 2030 (USD Million)
  • Table 8 North America NGS-based RNA-sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 9 North America NGS-based RNA-sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 10 North America NGS-based RNA-sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 11 North America NGS-based RNA-sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 12 U.S. NGS-based RNA-sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 13 U.S. NGS-based RNA-sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 14 U.S. NGS-based RNA-sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 15 U.S. NGS-based RNA-sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 16 Canada NGS-based RNA-sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 17 Canada NGS-based RNA-sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 18 Canada NGS-based RNA-sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 19 Canada NGS-based RNA-sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 20 Mexico NGS-based RNA-sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 21 Mexico NGS-based RNA-sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 22 Mexico NGS-based RNA-sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 23 Mexico NGS-based RNA-sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 24 Europe NGS-based RNA-sequencing market, by country, 2018 - 2030 (USD Million)
  • Table 25 Europe NGS-based RNA-sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 26 Europe NGS-based RNA-sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 27 Europe NGS-based RNA-sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 28 Europe NGS-based RNA-sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 29 Germany NGS-based RNA-sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 30 Germany NGS-based RNA-sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 31 Germany NGS-based RNA-sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 32 Germany NGS-based RNA-sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 33 UK NGS-based RNA-sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 34 UK NGS-based RNA-sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 35 UK NGS-based RNA-sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 36 UK NGS-based RNA-sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 37 France NGS-based RNA-sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 38 France NGS-based RNA-sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 39 France NGS-based RNA-sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 40 France NGS-based RNA-sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Italy NGS-based RNA-sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 42 Italy NGS-based RNA-sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 43 Italy NGS-based RNA-sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 44 Italy NGS-based RNA-sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 45 Spain NGS-based RNA-sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 46 Spain NGS-based RNA-sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 47 Spain NGS-based RNA-sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 48 Spain NGS-based RNA-sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 49 Denmark NGS-based RNA-sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 50 Denmark NGS-based RNA-sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 51 Denmark NGS-based RNA-sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 52 Denmark NGS-based RNA-sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 53 Sweden NGS-based RNA-sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 54 Sweden NGS-based RNA-sequencing market, by workflow, 2018-2030, (USD Million
  • Table 55 Sweden NGS-based RNA-sequencing market, by application, 2018-2030, (USD Million
  • Table 56 Sweden NGS-based RNA-sequencing market, by end use, 2018-2030, (USD Million
  • Table 57 Norway NGS-based RNA-sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 58 Norway NGS-based RNA-sequencing market, by workflow, 2018-2030, (USD Million
  • Table 59 Norway NGS-based RNA-sequencing market, by application, 2018-2030, (USD Million
  • Table 60 Norway NGS-based RNA-sequencing market, by end use, 2018-2030, (USD Million
  • Table 61 Asia Pacific NGS-based RNA-sequencing market, by country, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific NGS-based RNA-sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 63 Asia Pacific NGS-based RNA-sequencing market, by workflow, 2018-2030, (USD Million
  • Table 64 Asia Pacific NGS-based RNA-sequencing market, by application, 2018-2030, (USD Million
  • Table 65 Asia Pacific NGS-based RNA-sequencing market, by end use, 2018-2030, (USD Million
  • Table 66 China NGS-based RNA-sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 67 China NGS-based RNA-sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 68 China NGS-based RNA-sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 69 China NGS-based RNA-sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 70 Japan NGS-based RNA-sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 71 Japan NGS-based RNA-sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 72 Japan NGS-based RNA-sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 73 Japan NGS-based RNA-sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 74 India NGS-based RNA-sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 75 India NGS-based RNA-sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 76 India NGS-based RNA-sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 77 India NGS-based RNA-sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 78 South Korea NGS-based RNA-sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 79 South Korea NGS-based RNA-sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 80 South Korea NGS-based RNA-sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 81 South Korea NGS-based RNA-sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 82 Australia NGS-based RNA-sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 83 Australia NGS-based RNA-sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 84 Australia NGS-based RNA-sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 85 Australia NGS-based RNA-sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 86 Thailand NGS-based RNA-sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 87 Thailand NGS-based RNA-sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 88 Thailand NGS-based RNA-sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 89 Thailand NGS-based RNA-sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 90 Latin America NGS-based RNA-sequencing market, by country, 2018 - 2030 (USD Million)
  • Table 91 Latin America NGS-based RNA-sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 92 Latin America NGS-based RNA-sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 93 Latin America NGS-based RNA-sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 94 Latin America NGS-based RNA-sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 95 Brazil NGS-based RNA-sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 96 Brazil NGS-based RNA-sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 97 Brazil NGS-based RNA-sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 98 Brazil NGS-based RNA-sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 99 Argentina NGS-based RNA-sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 100 Argentina NGS-based RNA-sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 101 Argentina NGS-based RNA-sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 102 Argentina NGS-based RNA-sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 103 MEA NGS-based RNA-sequencing market, by country, 2018 - 2030 (USD Million)
  • Table 104 MEA NGS-based RNA-sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 105 MEA NGS-based RNA-sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 106 MEA NGS-based RNA-sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 107 MEA NGS-based RNA-sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 108 South Africa NGS-based RNA-sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 109 South Africa NGS-based RNA-sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 110 South Africa NGS-based RNA-sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 111 South Africa NGS-based RNA-sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 112 Saudi Arabia NGS-based RNA-sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 113 Saudi Arabia NGS-based RNA-sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia NGS-based RNA-sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia NGS-based RNA-sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 116 UAE NGS-based RNA-sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 117 UAE NGS-based RNA-sequencing market, by biomolecule type, 2018 - 2030 (USD Million)
  • Table 118 UAE NGS-based RNA-sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 119 UAE NGS-based RNA-sequencing market, by end use, 2018 - 2030 (USD Million)
  • Table 120 Kuwait NGS-based RNA-sequencing market, by product & service, 2018 - 2030 (USD Million)
  • Table 121 Kuwait NGS-based RNA-sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 122 Kuwait NGS-based RNA-sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 123 Kuwait NGS-based RNA-sequencing market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market formulation & validation
  • Fig. 4 NGS-based RNA-sequencing market: Market outlook
  • Fig. 5 NGS-based RNA-sequencing market: Segment outlook
  • Fig. 6 NGS-based RNA-sequencing market: Competitive landscape outlook
  • Fig. 7 Parent market outlook
  • Fig. 8 NGS-based RNA-sequencing market driver impact
  • Fig. 9 NGS-based RNA-sequencing market restraint impact
  • Fig. 10 NGS-based RNA-sequencing market: Product & services outlook and key takeaways
  • Fig. 11 NGS-based RNA-sequencing market: Product & services movement analysis
  • Fig. 12 Consumables market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 13 Extraction & purification kits market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 14 Library preparation kits market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 15 Labeling reagents & kits market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 16 Sequencing reagents & flow cells market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 17 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 18 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 RNA-sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Bioinformatics & data analysis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 NGS-based RNA-sequencing market: Workflow outlook and key takeaways
  • Fig. 23 NGS-based RNA-sequencing market: Workflow movement analysis
  • Fig. 24 Pre-sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Data analysis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 NGS-based RNA-sequencing market: Application outlook and key takeaways
  • Fig. 28 NGS-based RNA-sequencing market: Application movement analysis
  • Fig. 29 Drug discovery & development market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Oncology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Clinical diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 NGS-based RNA-sequencing market: End use outlook and key takeaways
  • Fig. 36 NGS-based RNA-sequencing market: End use movement analysis
  • Fig. 37 Pharmaceutical & biotechnology companies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Hospitals & clinical market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 39 Academic & research institutes market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 40 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Global NGS-based RNA-sequencing market: Regional outlook and key takeaways
  • Fig. 42 Global NGS-based RNA-sequencing market: Regional movement analysis
  • Fig. 43 North America NGS-based RNA-sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 U.S. NGS-based RNA-sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Canada NGS-based RNA-sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Mexico NGS-based RNA-sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Europe NGS-based RNA-sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 UK NGS-based RNA-sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Germany NGS-based RNA-sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 France NGS-based RNA-sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Italy NGS-based RNA-sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Spain NGS-based RNA-sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Denmark NGS-based RNA-sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Sweden NGS-based RNA-sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Norway NGS-based RNA-sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Asia Pacific NGS-based RNA-sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 China NGS-based RNA-sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Japan NGS-based RNA-sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 India NGS-based RNA-sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Thailand NGS-based RNA-sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 South Korea NGS-based RNA-sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Australia NGS-based RNA-sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Latin America NGS-based RNA-sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Brazil NGS-based RNA-sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Argentina NGS-based RNA-sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Middle East and Africa NGS-based RNA-sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 South Africa NGS-based RNA-sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Saudi Arabia NGS-based RNA-sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 UAE NGS-based RNA-sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Kuwait NGS-based RNA-sequencing market estimates and forecasts, 2018 - 2030 (USD Million)